Last $4.90 USD
Change Today 0.00 / 0.00%
Volume 0.0
CPIX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James L. Herman

Chief Compliance Officer and Vice President of National Accounts, Cumberland Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

59$288,790
As of Fiscal Year 2013

Background*

Mr. James Lowrance Herman serves as Vice President of National Accounts and Chief Compliance Officer at Cumberland Pharmaceuticals, Inc. Mr. Herman served as Senior Director of National Accounts and Corporate Compliance Officer of Cumberland Pharmaceuticals, Inc. He is responsible for all national accounts sales, including wholesalers and retail chain buying offices, managed care home Cumberland Pharmaceuticals, Inc. offices and federal government accounts. He is also ...

Read Full Background

Corporate Headquarters*

2525 West End Avenue
Nashville, Tennessee 37203

United States

Phone: 615-255-0068
Fax: 615-255-0094

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Indiana University, Bloomington
MBA
Cardinal Stritch University

Other Affiliations*

Annual Compensation*

Salary$192,500
Bonus$35,000
Total Annual Compensation$227,500

Stock Options*

Restricted Stock Awards$26,290

Total Compensation*

Total Annual Cash Compensation$227,500
Total Short Term Compensation$227,500
Other Long Term Compensation$26,290
Total Calculated Compensation$288,790
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CPIX:US $4.90 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael W. Bonney B.A.Chief Executive Officer and Director
Cubist Pharmaceuticals Inc.
$750.0K
David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
$916.2K
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$450.7K
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
$100.0K
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CUMBERLAND PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.